Methylene blue-mediated photodynamic therapy on cutaneous leishmaniasis

Carregando...
Imagem de Miniatura

Data

Data de publicação

2019

Orientador

Título da Revista

ISSN da Revista

Título do Volume

É parte de

É parte de

É parte de

É parte de

INTERNATIONAL PHOTODYNAMIC ASSOCIATION WORLD CONGRESS, 17th
Exportar
Mendeley

Projetos de Pesquisa

Unidades Organizacionais

Fascículo

Resumo
Cutaneous leishmaniasis (CL) is a neglected disease, which promotes destructive lesions. Difficulties in treatment are related to resistance and toxicity. Methylene blue-mediated photodynamic therapy (MB-PDT) has emerged as a promising treatment considering low cost and no reports about resistance. We evaluated MB-PDT on Leishmania amazonensis in vitro and in vivo using a red LED at different fluences. Our results demonstrated that the best fluence in vitro was not effective in vivo, and a higher dose was necessary to provide better responses in mice. This study reinforces the idea that a well-planned protocol is necessary for a successful MB-PDT on CL.

Como referenciar
CABRAL, FERNANDA V.; RIBEIRO, MARTHA S. Methylene blue-mediated photodynamic therapy on cutaneous leishmaniasis: an in vitro and in vivo study. In: INTERNATIONAL PHOTODYNAMIC ASSOCIATION WORLD CONGRESS, 17th, June 28 - July 4, 2019, Cambridge, Massachusetts, USA. Abstract... Disponível em: http://repositorio.ipen.br/handle/123456789/30951. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.

Agência de fomento